Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) of the Shares, provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) of the Shares, after notice duly given by the Company to each Investor.
Appears in 8 contracts
Samples: Registration Rights Agreement (StemGen, Inc.), Registration Rights Agreement (StemGen, Inc.), Registration Rights Agreement (StemGen, Inc.)
Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) holders of at least a majority of the Shares, Registrable Securities; provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) holders of at least a majority of the SharesRegistrable Securities, after notice duly given by the Company to each Investor.
Appears in 2 contracts
Samples: Registration Rights Agreement (Central European Distribution Corp), Registration Rights Agreement (Central European Distribution Corp)
Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) a majority of the SharesIssuable Shares (assuming conversion of the Notes and exercise of the Warrants), provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) a majority of the SharesIssuable Shares (assuming conversion of the Notes and exercise of the Warrants), after notice duly given by the Company to each Investor.
Appears in 2 contracts
Samples: Registration Rights Agreement (Pure Bioscience, Inc.), Registration Rights Agreement (Pure Bioscience, Inc.)
Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) of the Shares, provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s 's assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) of the Shares, after notice duly given by the Company to each Investor.
Appears in 1 contract
Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) of the SharesIssuable Shares (assuming conversion of the Notes and Series A Preferred Stock and exercise of the Warrants), provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) of the SharesIssuable Shares (assuming conversion of the Notes and Series A Preferred Stock and exercise of the Warrants), after notice duly given by the Company to each Investor.
Appears in 1 contract
Samples: Registration Rights Agreement (Opexa Therapeutics, Inc.)
Assignments and Transfers by the Company. This Agreement may not be assigned by the Company (whether by operation of law or otherwise) without the prior written consent of the Investors holding two thirds (66-2/3%) of the Purchased Shares, provided, however, that the Company may assign its rights and delegate its duties hereunder to any surviving or successor corporation in connection with a merger or consolidation of the Company with another corporation, or a sale, transfer or other disposition of all or substantially all of the Company’s assets to another corporation, without the prior written consent of the Investors holding two thirds (66-2/3%) of the Purchased Shares, after notice duly given by the Company to each Investor.
Appears in 1 contract
Samples: Registration Rights Agreement (Repros Therapeutics Inc.)